Showing results (221-230 of 313) with videos related to

Sort By:
Pageof 32
Frontiers in Aging Neuroscience|October 7, 2022
Metabolic syndrome predictors of brain gray matter volume in an age-stratified community sample of 776 Mexican- American adults: Results from the genetics of brain structure image archiveEithan Kotkowski, Larry R Price, Ralph A DeFronzo, et al.
The Journal of Clinical Endocrinology and Metabolism|February 17, 2010
Effects of pioglitazone on intramyocellular fat metabolism in patients with type 2 diabetes mellitusMandeep Bajaj, Rais Baig, Swangjit Suraamornkul, et al.
Diabetes, Obesity & Metabolism|October 7, 2022
Pioglitazone reduces epicardial fat and improves diastolic function in patients with type 2 diabetesAlexander J Moody, Marjorie Molina-Wilkins, Geoffrey D Clarke, et al.
Gene Therapy|August 4, 2018
Ectopic BAT mUCP-1 overexpression in SKM by delivering a BMP7/PRDM16/PGC-1a gene cocktail or single PRMD16 using non-viral UTMD gene therapyShuyuan Chen, Raul A Bastarrachea, Jin-Song Shen, et al.
Diabetes|July 16, 2025
Empagliflozin Enhances Hepatic Glucose Production and Reduces Total-Body Norepinephrine Turnover Rate: A Randomized TrialSiham Abdelgani, Ahmed Khattab, John M Adams, et al.
Plos One|December 2, 2011
Does reduced IGF-1R signaling in Igf1r+/- mice alter aging?Alex F Bokov, Neha Garg, Yuji Ikeno, et al.
Diabetes Care|April 30, 2003
Analysis of metabolic parameters as predictors of risk in the RENAAL studyGerald B Appel, Jai Radhakrishnan, Morrell M Avram, et al.
Diabetes Care|June 6, 2013
Characterization of renal glucose reabsorption in response to dapagliflozin in healthy subjects and subjects with type 2 diabetesRalph A DeFronzo, Marcus Hompesch, Sreeneeranj Kasichayanula, et al.
Diabetologia|July 2, 2013
Pioglitazone improves glucose metabolism and modulates skeletal muscle TIMP-3-TACE dyad in type 2 diabetes mellitus: a randomised, double-blind, placebo-controlled, mechanistic studyDevjit Tripathy, Giuseppe Daniele, Teresa V Fiorentino, et al.
Cerebellum (London, England)|November 7, 2020
Using the Schmahmann Syndrome Scale to Assess Cognitive Impairment in Young Adults with Metabolic Syndrome: a Hypothesis-Generating ReportEithan Kotkowski, Larry R Price, Cheasequah J Blevins, et al.
Pageof 32